Access the freely available AAPM 2020 CME REMS course, Strategies for Effective Pain Management, online.
AAPM is pleased to direct clinicians in pain medicine to this REMS-compliant training program made freely available online and that focuses on the safe prescribing of opioid analgesics.
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain versus the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse to manage patients’ pain and medication use optimally.
- Charles E. Argoff, MD, FABPM
- Oscar A. de Leon-Casasola, MD
- Katherine E. Galluzzi, DO, CMD, FACOFP
CME Accreditation and Credit Designation Statements
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Pri-Med Institute designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Certificates of Credit/Attendance for the REMS Course will be provided to attendees by Pri-Med Institute.
MOCA 2.0® Credits
Physicians in the “Strategies for Effective Pain Management” symposium may receive MOCA 2.0® credit upon completion of the session evaluation. Pri-Med Institute will report participant completion data to the American Board of Anesthesiology via the ACCME’s Program and Activity Reporting System (PARS) on behalf of the participant.
Maintenance of Certification in Anesthesiology™ program and MOCA 2.0® are registered trademarks of The American Board of Anesthesiology®. This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
ABPMR MOC Part II Lifelong Learning
Physicians in the “Strategies for Effective Pain Management” symposium will receive a CME credit certificate upon completion of the session evaluation, AMA PRA Category 1 Credit™ can be applied toward ABPMR MOC Part II Lifelong Learning CME credit; participants will need to report these CME credits directly into their ABPMR MOC Homepage.
This activity satisfies topic-specific CME requirements (pain management, controlled substances, etc) of many state licensing boards. Please check with your state’s licensing boards for specific requirements.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).
Clinicians who are eligible for the Merit-based Incentive Payment System (MIPS) can report participation in this CME activity as an Improvement Activity. This is a Medium weighted activity, in the Patient Safety and Practice Assessment sub-category. For group reporting (during CY 2020), a group or virtual group can attest to an activity when at least 50% of the clinicians in the group or virtual group perform the same activity during any continuous 90-day period (or as specified in the activity description) in the same performance year. For more information, visit qpp.cms.gov.
This REMS symposium will be available on-demand at www.pri-med.com in late March, to achieve 50% participation in your group.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see opioidanalgesicrems.com for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).